Abstract Background/Aims: Previous studies have suggested that autophagy is activated in distinct cerebrovascular diseases, including stroke. However, the underlying regulatory mechanism of autophagy under stroke remained elusive. Accumulating evidence indicates that dysfunctions of microRNAs (miRNAs) are involved in the pathological process of stroke. Therefore, this study was taken to identify the effect of microRNA-9a-5p (miR-9a-5p) on autophagy in rats following stroke. Methods: The rat model of focal cerebral ischemia was established by middle cerebral artery occlusion (MCAO) surgery; The neurological outcomes were defined by neurological evaluation and infarct volume; The western blotting and immunofluorescence assays were used to detected the protein levels of microtubule-associated protein 1 light chain 3 (LC3) and autophagy related 5 (ATG5); The mRNA level of miR-9a-5p, LC3 and ATG5 were quantified by real-time RT-PCR; The luciferase activities of ATG5 and miR-9a-5p was detected by luciferase assay. Results: We showed here that the level of miR-9a-5p was decreased in the ischemic region of rats after MCAO. Overexpression of miR-9a-5p by miR-9a-5p agomir reduced infarct volume and alleviated neurological deficit. Moreover, we found that autophagy was activated by miR-9a-5p inhibition and inactivated by miR-9a-5p overexpression both in the MCAO rat and in SY-5Y cell lines, and unchanged by miR-masks as indicated by LC3 expression. Furthermore, the protein level of ATG5 was decreased by miR-9a-5p overexpression, but increased by miR-9a-5p inhibition and unchanged by miR-masks transfection. In addition, the luciferase assay data showed that miR-9a-5p suppressed the luciferase activity of 3'UTR of ATG5, whereas the repressive effect was relieved by mutation of binding sites. Conclusion: Our study demonstrated that miR-9a-5p may play a critical role in regulating the process of autophagy through targeting ATG5 expression, and overexpression of miR-9a-5p may be a potential approach in alleviating ischemia injury induced by MCAO.
Introduction
Globally, the incidence of stroke is growing at an alarming rate, and becomes a serious public health problem [1] [2] [3] [4] . Exception of energy attenuation, oxidative stress, apoptosis, activated inflammation response, autophagy is considered as a new pathological mechanism for stroke [5] . Autophagy, a conserved cellular self-digestive process via lysosome, is responsible for degradation of damaged proteins and organelles [6, 7] . Recently, there is evidence that autophagy, termed type II programmed cell death, is a form of cell death that arises during ischemic stroke. For example, Rami et al. found that the autophagy was activated in rats following ischemia [8] . Atg7 is the essential gene for autophagy induction, however, selective deficient in Atg7 could inactive autophagy and protect against neuronal death in hypoxia-ischemic injury [9] . Inhibition of AMPK could mitigate ischemia injury via inhibiting autophagy in mice [10] . Electroacupuncure could protect against ischemic stroke through autophagy inactivation [11] . All the studies suggested that inhibition of autophagy may be a potential target for stroke. However, the underlying regulatory mechanisms of autophagy in stroke are incompletely understood.
MicroRNAs (miRNAs) are a kind of endogenous non-coding RNAs that regulate the expression of target gene through transcription inhibition or mRNA degradation [12, 13] . Numerous studies have demonstrated that miRNAs are contributed to the pathophysiology of stroke. For example, miR-137 could protect neuron injury from oxygen-glucose deprivation and reoxygenation by directly binding with Notch 1 [14] . Stroke was shown to decrease miR-181 both in brain of patients suffering with acute ischemic stroke and mouse brain subjected to middle cerebral artery occlusion. However, overexpression of miR-181 by miR-181 agomir induced infarct volume and reduced microglia activation [15] . MicroRNA-455 is involved in inhibiting neuronal death by regulating TRAF3 expression in cerebral ischemic stroke [16] , which suggesting that miRNAs may be as mediators under stroke status.
Evidence showed that microRNA-9a-5p is highly expressed in the brain, and its expression was dysfunction in neurodegenerative diseases, including stroke. However, the effect of miR-9a-5p on autophagy under stroke status is incompletely understood. Thus, the aim of our study is to identify the function of miR-9a-5p on autophagy and clarify the relative mechanism.
Materials and Methods

Focal cerebral ischemia model
Male Wistar rats (obtained from the Animal Centre at the Second Affiliated Hospital of Harbin Medical University) were housed in a SPF level environment room. The middle cerebral artery occlusion (MCAO) surgery was performed to establish focal cerebral ischemia in rats as described previous studies [17, 18] . After anesthetized by administration of 10% chloral hydrate (300 mg/kg, ip), the right common carotid artery of rat was exposed and dissected. A nylon filament-coated with paraffin wax was slowly inserted into the right internal carotid artery from the external carotid artery for 24 h. The sham-operated rats were performed identically without the thread inserted. The agomir-9a-5p (12 mg/kg body weight, Cat.no: P1031) or negative control (12 mg/kg body weight, Cat.no: Q0301) was lateral cerebral ventricle injected for 3 days prior MCAO surgery.
Neurological evaluation and Measurement of infarct volume
Neurological evaluation of MCAO was performed by two observers who were blinded to the procedures, and scored on 5-point scale was chosen as following: 0, no impairment for rats; 1, mild neurologic deficit; 2, moderate neurologic deficit; 3, severe neurologic deficit; 4, no walk spontaneously. For measurement of infarct volume, the MCAO rats were anesthetized with chloral hydrate (300 mg/kg, ip), the brain were quickly removed, and the 2, 3, 5-Triphenyltetrazolum Chloride (TTC) staining was performed to detect the infarct volume. The infarct ration was calculated by the formula: corrected percentage of infarct volume = (contralateral hemispheric volume-ipsilateral non-infarcted volume) / contralateral hemispheric volume×100 %. Cell culture and OGD SY-5Y cells were cultured in Dulbecco's-Modified Essential Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 U/ml penicillin and 100U/ml streptomycin. For oxygen-glucose deprivation (OGD), briefly, the cells were incubated in glucose-free DMEM media in humidified incubator (95% N 2 and 5% CO 2 ) for 3 h. Subsequently, the cells were return to normal medium and normal incubator condition for 12 h.
Cell transfection
MicroRNA-9a-5p mimics (Cat.no: P0412) and AMO-9a-5p (Cat.no: Q0413) were synthesized by Guangzhou RiboBio Co., Ltd.). The ATG5 antisense oligodeoxynecleotides (masking-9a-5p) was synthesized by Sangon Biotech (Shanghai) Co.,Ltd., the sequences was 3`-CGACGACGTTCGGTTCCGCCGTC -5`. The ends of four nucleotides were modicated by 2`-Ome. And then, miR-9a-5p mimics, AMO-9a-5p or masking was transfected into SY-5Y cells by using Lipofectamine™ 3000 transfection reagent according to the manufacturer's instructions. After 48 h transfection, the non-treated or treated cells were collected for further experiments.
Western blotting analysis
Tissue proteins were extracted from the right peri-infarct cortical tissue of MCAO rats and the corresponding area of sham rats, they were prepared using Radio-Immunoprecipitation Assay (RIPA) lysis buffer from Beyotime Institute of Biotechnology (Cat.no: P0013B) containing protease inhibitor cocktail (Roche). The lyses were collected by centrifugation at 13, 000 rpm at 4 °C for 30 mins. Samples concentrations were measured by the BCA kit from Beyotime Institute of Biotechnology according to the manufacturer's instructions (Cat.no: P0009). Protein samples were separated on SDS-PAGE gel, and then transferred onto PVDF membranes. After blocking in 5 % non-fat dry milk for 2 h, the following primary antibodies were incubated at 4°C for overnight: anti-LC3 (1:1000, L7543, Sigma, Saint Louis, MO, USA), anti-ATG5 (1:500, 10181-2-AP, proteintech, China) and anti-β-actin (1:1000, 60008-1-lg, proteintech, China). On the next day, the membranes were washed with TBS + Tween (TBS-T) and incubated with the secondary antibody for 1 h. The bands were captured on Odyssey Infrared Imaging System (LI-COR) and quantified with Odyssey v1.2 software.
Immunofluorescence assay
The non-treated SY-5Y cells or treated SY-5Y cells were fixed with 4 % paraformaldehyde at 37 °C for 30 min. After blocking and permeabilization using buffer A (PBS+10% donkey serum+0.1% TritonX-100) for 1h at room temperature, the antibody for LC3 (1:500, L7543, Sigma, Saint Louis, MO, USA) and ATG5 (1:200, 10181-2-AP, proteintech, China) were incubated at 4 °C for overnight. In the next day, the secondary antibody conjugated to Alexa Fluor 594 donkey Anti-rabbit (1:1000, A21207, Invitrogen, CA, USA) and Alexa Fluor 488 Donkey Anti-Rabbit (1:1000, A-21206, Invitrogen, CA, USA) was incubated for 1 h at room temperature. The images were captured by Zeiss microscope.
Real-time RT-PCR
Total RNA was isolated from the brain of rats and the non-treated or treated SY-5Y cells with TRIZOL reagent (Invitrogen, USA) according to manufacturer's instructions. The cDNA was reversed from 0.5 μg RNA and real-time PCR was performed by using ReverTra Ace qPCR RT Master Mix (Cat.no: FSQ-201) according to the manufacturer's instructions. The primers sequences used in this study were shown in Table 1 . U6 or β-actin was an internal control, and the relative level of miR-9a-5p, ATG5 and LC3 were calculated by using the 2 -∆∆Ct method.
Luciferase assays
The luciferase reporter construct containing 3'UTR of ATG5 gene (Atg5) were synthesized by Guangzhou RiboBio Co., Ltd, in which includes the potential binding site of the miR-9a-5p seed sequence. HEK293-T cells were plated at 40~60 % confluence, and then miR-9a-5p mimics was transfected with plasmid by using Lipofectamine™ 2000 transfection reagent in compliance to the manufacturer's instructions. After 48 h transfection, luciferase activity assay was performed by dual luciferase reporter assay kit from Promega.
Results
Effect of miR-9a-5p on neurological disorders after MCAO
To identify the role of miR-9a-5p in MCAO rats, we first detected the level of miR9a-5p in peri-infarct cortical tissue after focal cerebral ischemia. As shown in Fig.1A , we found that miR-9a-5p was decreased in MACO rats compared with sham-operated rats. We then asked whether decreased miR-9a-5p is involved in ischemia injury initiation and maintenance. To answer this question, miR-9a-5p agomir was injected to overexpression of miR-9a-5p in brain in this study. The results showed that miR-9a-5p agomir significantly increased miR-9a-5p level in MCAO rats (Fig. 1B) . As illustrated in Fig. 1C , compared with MCAO group, overexpression of miR-9a-5p reduced the infarct volume after MCAO injury. Moreover, compared to MCAO group, we found that upregulation miR-9a-5p by miR-9a-5p agomir injection significantly decreased the neurological deficit score induced by MCAO surgery (Fig. 1D) . These results indicated that elevated miR-9a-5p could partially rescue the neurological disorders in the MACO rats.
Effect of miR-9a-5p on autophagy in rats after MCAO
Previous studies that demonstrated that autophagy are activated in the rats after MCAO injury; however, whether miR-9a-5p is involved in autophagy under ischemic injury condition is unclear. Therefore, in the present study, we first measured the change of autophagy. Microtubule-associated protein 1 light chain 3 (LC3) is effective marker for autophagy activation, western blotting analysis revealed an increase in the protein and mRNA level of LC3, however, its level was decreased by miR-9a-5p agomir injection ( Fig.  2A &B) . Interestingly, the protein level of autophagy related 5 (ATG5), the essential gene for autophagy induction, was elevated by MCAO surgery, but decreased by miR-9a-5p overexpression, but its mRNA level was unchanged (Fig. 2C &D) . All the data suggested that abnormal miR-9a-5p may be involved in autophagy accumulation in the rats after MCAO, and post-transcriptional regulation mechanism between miR-9a-5p and ATG5 may be involved in MCAO surgery.
ATG5 is a target of miR-9a-5p
Next step, we tried to further investigate the molecular mechanism. By using miRNA database, we found that ATG5 gene (Atg5) is a potential target of miR-9a-5p. Moreover, we established the relationship between miR-9a-5p and ATG5 by using gain-and loss-of-function approaches. As shown in Fig. 3A , miR-9a-5p significantly inhibited luciferase activities of Atg5, while the repressive effects of miR-9a-5p on 3'UTR of Atg5 was decreased by mutation binding sites. To observe the effect of miR-9a-5p on the expression of ATG5, miR-9a-5p mimics and AMO-9a-5p were transfected into SY-5Y cells. The result showed that miR-9a-5p mimics or AMO-9a-5p was successfully transfected (Fig. 3B) . Western blotting analysis showed that overexpression of miR-9a-5p could decrease ATG5 protein level compared with the control group, while, inhibition of miR-9a-5p by AMO-9a-5p lead to increase in ATG5 (Fig. 3C ). This result was further identified by immunofluorescences staining assay (Fig. 3D ). All the above results suggested that ATG5 is a target of miR-9a-5p.
MiR-9a-5p affects autophagy via regulating ATG5
Our foregoing results showed that miR-9a-5p not only regulated the expression of ATG5, but also affected the level of LC3 in MACO rats. The next question is whether miR-9a-5p also exerts function on affecting autophagy via regulating ATG5 expression. We designed miRNAmasking antisense oligodeoxynucleotides (masking-9a-5p) sequence, which could not directly interact with miR-9a-5p, but bind to the 3' UTR of Atg5 gene by fully complementary mechanism; hence it was different from AMO-9a-5p (Fig. 4A) . As shown in Fig. 4B , similar with our prediction, decreased ATG5 level induced by miR-9a-5p overexpression was prevented by transfection masking-9a-5p. The result was further identified by immunofluorescences staining assay (Fig. 4C) . In addition, transfection of masking-9a-5p could lead to increase the protein and mRNA levels of LC3 (Fig. 4D&4E) . All the results suggested the miR-9a-5p affects autophagy via directly regulating ATG5 expression.
Effect of miR-9a-5p on autophagy in OGD cells
Next step, we want to further investigate the effect of miR-9a-5p on autophagy in vitro. As illustrated in Fig. 5A , compared with the control group, the level of miR-9a-5p was significantly decreased in SY-5Y cells with OGD insult. Overexpression of miR-9a-5p by miR9a-5p mimics successfully reverses decreased miR-9a-5p level in OGD cells. As predicted, we found that OGD marked elevated, while overexpression of miR-9a-5p after OGD significantly decreased the protein levels of LC3 and ATG5 (Fig. 5B & C) . This result was further identified by immunofluorescences staining assay (Fig. 5D & E) , indicating that miR-9a-5p may contribute to mediate autophagy in vitro.
Discussion
In our present study, we found that the level of miR-9a-5p was decreased in the ischemic region of rats after MCAO. Overexpression of miR-9a-5p by miR-9a-5p agomir reduced infarct volume and alleviated neurological deficit. Moreover, we found that autophagy was activated by miR-9a-5p inhibition, inactivated by miR-9a-5p overexpression and unchanged by miR-masks transfection both in MCAO rat and in SY-5Y cell lines. Furthermore, miR-9a-5p regulated the expression of ATG5 evidenced by western blotting, immunofluorescence staining and luciferase assays. Therefore, this observation indicates that miR-9a-5p mediated-autophagy was involved in ischemic injury induced by MCAO in rats.
As far as we know, autophagy plays a critical role in ischemia injury. Autophagy is consider as exerting a protective effect on brain injury at acute stage, whereas long-term autophagy could induce cell death, which is termed as type II programmed cell death [19, 20] . Previous studies have demonstrated that cerebral ischemia induces autophagy as evidence by increased LC3 and Beclin1 [8] . A recent study reported that inactive autophagy by 3-methyladenine (3-MA) treatment attenuated secondary damage after ischemia injury [21] . Similar with previous studies, we also found that MCAO induced autophagy accompanied with elevated LC3 and ATG5 expression, which suggested that inhibition of autophagy may be a potential therapeutic target for stroke.
Increasing evidences have been indicated that microRNAs are involved in the different pathogenic process of ischemia injury in brain, including atheroscherosis, hypertension, hyperlipdiemia and stroke. MicroRNA-9 is highly expressed in brain, which contributes to neurogenesis, proliferation, plasticity, axon extension, and so on [22] [23] [24] [25] . In addition, under pathological status, the expression of miR-9 was dysregulated in different neurodegenerative disease, including Alzheimer's disease, Huntington's disease and Stroke [17, 26, 27] . Similar with previous study, we also found that the level of miR-9a-5p was significantly decreased both in the MCAO rat, pre-treatment with miR-9a-5p agomir has been shown to reduce infract volume and alleviate neurological deficit after MCAO surgery, which suggested that miR-9a-5p may be a potential therapeutic target for stroke .
Previous studies have demonstrated that microRNAs play a key role in regulating autophagy in neurodegenerative disease. For example, che et al. found that the level of miR-27a was increased in rat under chronic brain hypoperfusion condition, which induced the accumulation of autophagosomes via regulating LAMP2 expression in neuron [28] . Overexpression of miR-23b exerted neuroprotective effects on cognitive impairments after traumatic brain injury via inhibiting neuron apoptosis and attenuating neurological deficits [29] . MCAO reduced miR-207 level in rats, which directly targeted to lysosomal-associated membrane protein 2 and affected the lysosomal-autophagy pathway for mediating ischemic injury [30] . In our present study, we also found that autophagy was activated by miR-9a-5p knockout, whereas was inactivated by miR-9a-5p overexpression both in vivo and in vitro. In addition, we also found that overexpression of miR-9a-5p down-regulated, while inhibition of miR-9a-5p up-regulated the expression of ATG5 both in the MCAO rat and in OGD SY-5Y cells. In addition, the level of ATG5 was unchanged by miR-masks (masking-9a-5) transfection. These results indicated that ATG5 is a target of miR-9a-5p, overexpression of miR-9a-5p exerts neuroprotective effect on ischemic injury via mediating autophagy.
Our present study has demonstrated that miR-9a-5p may play a critical role in regulating the process of autophagy by targeting ATG5 expression, and overexpression of miR-9a-5p may be a potential approach in alleviating ischemia injury induced by MCAO.
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